Showing results (671-680 of 679) with videos related to

Sort By:
Pageof 68
You have reached the last page of results.This site can display upto 679 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 13, 2025
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Nicola Cersullo, et al.
International Journal of Cardiology|April 10, 2017
A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis. The EndoSCOREMichele Di Mauro, Guglielmo Mario Actis Dato, Fabio Barili, et al.
Expert Opinion on Biological Therapy|January 22, 2024
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life studyAntonio Tursi, Giammarco Mocci, Franco Scaldaferri, et al.
Advances in Therapy|May 9, 2026
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort StudyAntonio Tursi, Andrea Pasta, Walter Elisei, et al.
Expert Opinion on Biological Therapy|February 27, 2023
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter studyGiammarco Mocci, Antonio Tursi, Giovanni Maconi, et al.
Journal of Clinical Medicine|November 13, 2025
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World StudyGiammarco Mocci, Antonio Tursi, Franco Scaldaferri, et al.
Biological Psychiatry|August 28, 2022
Brain Structure in Acutely Underweight and Partially Weight-Restored Individuals With Anorexia Nervosa: A Coordinated Analysis by the ENIGMA Eating Disorders Working GroupEsther Walton, Fabio Bernardoni, Victoria-Luise Batury, et al.
Journal of Clinical Medicine|December 17, 2024
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort StudyGiammarco Mocci, Antonio Tursi, Franco Scaldaferri, et al.
American Journal of Therapeutics|July 23, 2026
Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life StudyAntonio Tursi, Giammarco Mocci, Franco Scaldaferri, et al.
Pageof 68